{"id":304384,"date":"2025-07-30T01:07:10","date_gmt":"2025-07-30T01:07:10","guid":{"rendered":"https:\/\/www.europesays.com\/de\/304384\/"},"modified":"2025-07-30T01:07:10","modified_gmt":"2025-07-30T01:07:10","slug":"biontech-aktie-gibt-nach-partnerschaft-mit-bristol-myers-squibb-zur-fokussierung-auf-krebsforschung-finanzen-net","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/304384\/","title":{"rendered":"BioNTech-Aktie gibt nach: Partnerschaft mit Bristol Myers Squibb zur Fokussierung auf Krebsforschung – Finanzen.net"},"content":{"rendered":"
    \n
  1. BioNTech-Aktie gibt nach: Partnerschaft mit Bristol Myers Squibb zur Fokussierung auf Krebsforschung<\/a>  Finanzen.net<\/li>\n
  2. Biontech \u2013 der Neustart von Deutschlands Pharma-Hoffnung<\/a>  Capital.de<\/li>\n
  3. Achtung bei BioNTech! Bayer, Formycon und Vidac Pharma Aktie drehen auf!<\/a>  ESG-Aktien<\/li>\n
  4. BioNTech-Aktie vor n\u00e4chster Rallye? Auf diese 2 Dinge warten jetzt alle Anleger<\/a>  B\u00f6rse Online<\/li>\n
  5. BioNTech Aktie: Revolution oder Rohrkrepierer?<\/a>  B\u00f6rse Express<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"BioNTech-Aktie gibt nach: Partnerschaft mit Bristol Myers Squibb zur Fokussierung auf Krebsforschung  Finanzen.net Biontech \u2013 der Neustart von Deutschlands…\n","protected":false},"author":2,"featured_media":6787,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[134],"tags":[175,170,169,29,30,171,174,173,172],"class_list":{"0":"post-304384","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-unternehmen-maerkte","8":"tag-business","9":"tag-companies","10":"tag-companies-markets","11":"tag-deutschland","12":"tag-germany","13":"tag-markets","14":"tag-maerkte","15":"tag-unternehmen","16":"tag-unternehmen-maerkte"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/114939510920580545","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/304384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=304384"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/304384\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/6787"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=304384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=304384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=304384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}